DOBUTAMINE HYDROCHLORIDE

Post-LOE

dobutamine

Hikma

ANDAINJECTIONINJECTABLE

Approved

Oct 1994

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

2/8 — Basic

Drug data last refreshed 18h ago

Mechanism of Action

Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.

Indications

Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.

Clinical Trials (13)

NCT06973902N/ARecruiting

The Predictive Value of Dobutamine Echo-stress in the Clinical Response to CCM Therapy in Advanced HF

Started Jul 2025

120 enrolled

Symptomatic Congestive Heart Failure

NCT07000994N/ACompleted

Dobutamine During Major Abdominal Surgery

Started Jun 2025

100 enrolled

Intraoperative Myocardial Depression

NCT06462313N/ACompleted

Dobutamine for Management of Surgical Patients With Septic Shock

Started Jun 2024

584 enrolled

Patients With Septic ShockSurgical PatientsGeneral Anesthesia

NCT05350592Phase 2Active Not Recruiting

Low-Dose Dobutamine and Single-Dose Tocilizumab in Acute Myocardial Infarction With High Risk of Cardiogenic Shock

Started Mar 2022

100 enrolled

Acute Myocardial InfarctionCardiogenic Shock

NCT03387605Phase 4Unknown

Effect of Ivabradine in Stage D HF/Cardiogenic Shock Patients on Dobutamine

Started Mar 2018

40 enrolled

Heart FailureCardiogenic ShockTachycardia

Worked on DOBUTAMINE HYDROCHLORIDE at Hikma? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.